Patients given aprotinin, a drug used to limit blood loss in heart bypass surgery, are at greater risk of dying over the next five years than those given two other medications, a new study finds.

The report is published in the issue of the Journal of the American Medical Association, comes from the same group that last year linked aprotinin to an increased risk of kidney failure, heart failure and stroke..

here's the link http://www.healthday.com/Article.asp?AID=601661